142 related articles for article (PubMed ID: 4153830)
1. A critical assessment of methods for the determination of monoamine synthesis turnover rates in vivo.
Weiner N
Adv Biochem Psychopharmacol; 1974; 12(0):143-59. PubMed ID: 4153830
[No Abstract] [Full Text] [Related]
2. Neuropsychopharmacology of monoamines and their regulatory enzymes.
Lipton MA
Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
[No Abstract] [Full Text] [Related]
3. Biogenic amines in the developing brain.
Eiduson S
UCLA Forum Med Sci; 1971; 14():391-418. PubMed ID: 4399509
[No Abstract] [Full Text] [Related]
4. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
Davis JN; Carlsson A
J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239
[No Abstract] [Full Text] [Related]
5. [The pineal body].
Montilla Lopez P
Rev Clin Esp; 1972 Jul; 126(1):1-12 contd. PubMed ID: 4404675
[No Abstract] [Full Text] [Related]
6. Appraisal of current methods to estimate the turnover rate of serotonin and catecholamines in human brain.
Costa E
Adv Biochem Psychopharmacol; 1972; 4():171-83. PubMed ID: 4402386
[No Abstract] [Full Text] [Related]
7. Measurements of monoamine synthesis and turnover with special reference to 5-hydroxytryptamine.
Carlsson A
Adv Biochem Psychopharmacol; 1974; 10():75-81. PubMed ID: 4152552
[No Abstract] [Full Text] [Related]
8. Biochemical aspects of experimentally induced parkinsonism.
Goldstein M; Anagnoste B; Battista AF; Nakatani S; Ogawa M
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():434-47. PubMed ID: 4403657
[No Abstract] [Full Text] [Related]
9. Brain monoamines. Biosynthesis and fate.
Axelrod J
Neurosci Res Program Bull; 1971 Mar; 9(2):188-96. PubMed ID: 4152628
[No Abstract] [Full Text] [Related]
10. [Methods of determination of the turnover rate of neuromediators (author's transl)].
Poitou P; Bohuon C
Pathol Biol (Paris); 1976 Feb; 24(2):149-52. PubMed ID: 5695
[TBL] [Abstract][Full Text] [Related]
11. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
Yang HY; Neff NH
J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
[No Abstract] [Full Text] [Related]
12. Proceedings: A critical assessment of methods for the determination of monoamine synthesis and turnover rates in vivo.
Weiner N
Psychopharmacol Bull; 1974 Jul; 10(3):28-9. PubMed ID: 4419298
[No Abstract] [Full Text] [Related]
13. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
[No Abstract] [Full Text] [Related]
14. Daily variations in monoamine turnover in the brain of the ring dove (Streptopelia risoria).
Lea RW; Hall TR; Vowles DM
Neuroscience; 1987 May; 21(2):639-45. PubMed ID: 2886956
[TBL] [Abstract][Full Text] [Related]
15. The concentrations of the monoamines and their precursor amino acids in three areas of mouse brain during pregnancy.
Greengrass PM; Tonge SR
Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):75-84. PubMed ID: 4441185
[No Abstract] [Full Text] [Related]
16. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
Symchowicz S; Korduba CA; Veals J
Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
[No Abstract] [Full Text] [Related]
17. Stereoisomers of viminol: catalepsy and brain monoamine turnover rate.
Costa E; Cheney D; Revuelta A
Adv Biochem Psychopharmacol; 1973; 8(0):483-94. PubMed ID: 4800183
[No Abstract] [Full Text] [Related]
18. Metabolic rates and multiple functional pools of brain biogenic amines: their significance in neuroendocrine regulation.
Hyyppä MT
Med Biol; 1974 Jun; 52(3):170-5. PubMed ID: 4418205
[No Abstract] [Full Text] [Related]
19. [Effects of external factors on biogenic cerebral amines].
Schrammowa H; Rybakowski J
Psychiatr Pol; 1972; 6(2):225-7. PubMed ID: 4402133
[No Abstract] [Full Text] [Related]
20. The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals.
Iversen LL; Glowinski J; Axelrod J
J Pharmacol Exp Ther; 1966 Feb; 151(2):273-84. PubMed ID: 5932603
[No Abstract] [Full Text] [Related]
[Next] [New Search]
